Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: J Pain Symptom Manage. 2016 Dec 29;53(3):571–577. doi: 10.1016/j.jpainsymman.2016.09.016

Table 1.

Baseline characteristics (N=366)

Characteristics N (%)*
Age, average (range) 58 (21–90)
Female sex 168 (46)
Race
White 242 (66)
Black 59 (16)
Hispanic 39 (11)
Other 26 (7)
Cancer type
Breast 50 (14)
Gastrointestinal 111 (30)
Genitourinary 20 (6)
Gynecological 34 (9)
Head and neck 48 (13)
Hematologic 8 (2)
Respiratory 40 (11)
Other 55 (15)
Edmonton Symptom Assessment Scale, mean (SD)
Pain 4.2 (3.0)
Fatigue 5.2 (2.9)
Nausea 2.0 (2.7)
Depression 2.7 (2.9)
Anxiety 3.1 (3.1)
Drowsiness 3.5 (3.1)
Dyspnea 3.1 (3.2)
Appetite 4.7 (3.1)
Well being 4.5 (2.9)
Sleep 4.7 (2.9)
ECOG Performance status
0–1 81 (22.6)
2 147 (41.1)
3 130 (36.3)
4 0
Percentage weight loss over past 6 months, mean (SD) 7.8 (14.6)
Serum albumin in g/dL, mean (SD) 3.8 (0.7)
Hypercalcemia (corrected calcium >10.2 mg/dL) 11 (4.1)
Lactate dehydrogenase in unit, mean (SD) 778.5 (1226.2)
Leukocytosis (serum leukocyte >11,000/mm3) 40 (12.0)
Lymphopenia (lymphocyte <1%) 140 (42.2)
Anemia (hemoglobin <8.0 g/dL) 13 (3.9)
Neutrophil-lymphocyte ratio, mean (SD) 5.9 (7.0)

Abbreviations: ECOG, Eastern Cooperative Oncology Group

*

Unless otherwise specified